Kokilavani Sivaraman
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Kokilavani Sivaraman has a total of 24 co-authors. Here are the top co-authors by number of shared publications:
- Beata Olejnicka
Department of Respiratory Medicine, German Center for Lung Research (DZL), Biomedical Research in Endstage and Obstructive Lung Disease Hannover (BREATH), Hannover Medical School, 30625 Hannover, Germany
3 shared publications - Florian M. Wurm
ExcellGene SA, 1970 Monthey, Switzerland
3 shared publications - Maria João Wurm
ExcellGene SA, 1970 Monthey, Switzerland
3 shared publications - Paco Pino
ExcellGene SA, 1970 Monthey, Switzerland
3 shared publications - Sabina Janciauskiene
Department of Respiratory Medicine, Hannover Medical School, Hannover, Germany
3 shared publications - Sabine Wrenger
Department of Pulmonary and Infectious Diseases, BREATH German Center for Lung Research (DZL) Hannover University School, Hannover, Germany
3 shared publications
Latest Publications
- 14 September 2024
- Published by European Respiratory Society (ERS) in European Respiratory Journal
- Vol. 64 (suppl 68) , PA1733
α1-Antitrypsin regulates CXCR2 surface expression in human neutrophils via IL-8 release and expression
Neutrophil activation and migration are regulated by IL8 dependent internalization and subsequent re-expression of chemokine receptor CXCR2. A rapid modulation of CXCR2 by IL8 is associated with IL8-driven neutrophil migration. α1-Antitrypsin (AAT) binds IL8 and is a regulator of IL8-induced neutrophil migration, but the effect of AAT on CXCR2 expression is unknown. Isolated human blood neutrophils were treated with AAT (Prolastin, 1 mg/ml) and/or IL8 (50 ng/ml) and/or lipopolysaccharide (LPS, 10 ng/ml) for 1, 4 and 24h. After, neutrophils were stained with CXCR2/IL8 and CXCR1 fluorescein-conjugated antibody and flow cytometry was performed. The levels of IL8 in cell supernatants were quantified by ELISA and CXCR2 and IL8 gene expression levels were checked using qRT-PCR. As expected, exposure of neutrophils to IL8 resulted in a transient internalization and a subsequent re-expression (at 4h) of surface CXCR2 without affecting CXCR2 mRNA. In contrast, LPS did not affect surface CXCR2 levels within 1h, but reduced CXCR2 expression at 4 and 24h. Addition of AAT greatly increased the internalization of CXCR2 in IL8 or LPS treated neutrophils at 1h, showed no effect at 4h, and, independent of the presence of stimuli, increased surface levels of CXCR2 at 24h. These changes in CXCR2 levels paralleled the effect of AAT on IL8 release and expression. While AAT in the short term significantly enhanced IL8 and LPS-induced IL8 release, at 4 and 24h AAT inhibited LPS-induced IL8 release. Finally at 24h, AAT by itself reduced IL8 mRNA expression. Our data show that exogenously added AAT regulates CXCR2 expression in neutrophils by inducing time-dependent changes in IL8 release and expression.
- 14 September 2024
- Published by European Respiratory Society (ERS) in European Respiratory Journal
- Vol. 64 (suppl 68) , PA1733
α1-Antitrypsin regulates CXCR2 surface expression in human neutrophils via IL-8 release and expression
Neutrophil activation and migration are regulated by IL8 dependent internalization and subsequent re-expression of chemokine receptor CXCR2. A rapid modulation of CXCR2 by IL8 is associated with IL8-driven neutrophil migration. α1-Antitrypsin (AAT) binds IL8 and is a regulator of IL8-induced neutrophil migration, but the effect of AAT on CXCR2 expression is unknown. Isolated human blood neutrophils were treated with AAT (Prolastin, 1 mg/ml) and/or IL8 (50 ng/ml) and/or lipopolysaccharide (LPS, 10 ng/ml) for 1, 4 and 24h. After, neutrophils were stained with CXCR2/IL8 and CXCR1 fluorescein-conjugated antibody and flow cytometry was performed. The levels of IL8 in cell supernatants were quantified by ELISA and CXCR2 and IL8 gene expression levels were checked using qRT-PCR. As expected, exposure of neutrophils to IL8 resulted in a transient internalization and a subsequent re-expression (at 4h) of surface CXCR2 without affecting CXCR2 mRNA. In contrast, LPS did not affect surface CXCR2 levels within 1h, but reduced CXCR2 expression at 4 and 24h. Addition of AAT greatly increased the internalization of CXCR2 in IL8 or LPS treated neutrophils at 1h, showed no effect at 4h, and, independent of the presence of stimuli, increased surface levels of CXCR2 at 24h. These changes in CXCR2 levels paralleled the effect of AAT on IL8 release and expression. While AAT in the short term significantly enhanced IL8 and LPS-induced IL8 release, at 4 and 24h AAT inhibited LPS-induced IL8 release. Finally at 24h, AAT by itself reduced IL8 mRNA expression. Our data show that exogenously added AAT regulates CXCR2 expression in neutrophils by inducing time-dependent changes in IL8 release and expression.
- Open Access
- 1 November 2023
- Published by MDPI AG in Microorganisms
- Vol. 11 (11) , 2683
Human PBMCs Form Lipid Droplets in Response to Spike Proteins
Intracellular lipid droplets (LDs) can accumulate in response to inflammation, metabolic stresses, and other physiological/pathological processes. Herein, we investigated whether spike proteins of SARS-CoV-2 induce LDs in human peripheral blood mononuclear cells (PBMCs) and in pulmonary microvascular endothelial cells (HPMECs). PBMCs or HPMECs were incubated alone or with endotoxin-free recombinant variants of trimeric spike glycoproteins (Alpha, Beta, Delta, and Omicron, 12 µg/mL). Afterward, cells were stained with Oil Red O for LDs, cytokine release was determined through ELISA, and the gene expression was analyzed through real-time PCR using TaqMan assays. Our data show that spikes induce LDs in PBMCs but not in HPMECs. In line with this, in PBMCs, spike proteins lower the expression of genes involving lipid metabolism and LD formation, such as SREBF1, HMGCS1, LDLR, and CD36. On the other hand, PBMCs exposed to spikes for 6 or 18 h did not increase in IL-1β, IL-6, IL-8, MCP-1, and TNFα release or expression as compared to non-treated controls. Thus, spike-induced LD formation in PBMCs seems to not be related to cell inflammatory activation. Further detailed studies are warranted to investigate in which specific immune cells spikes induce LDs, and what are the pathophysiological mechanisms and consequences of this induction in vivo.
- 1 November 2023
- Published by MDPI AG in Microorganisms
- Vol. 11 (11) , 2683
Open AccessHuman PBMCs Form Lipid Droplets in Response to Spike Proteins
Intracellular lipid droplets (LDs) can accumulate in response to inflammation, metabolic stresses, and other physiological/pathological processes. Herein, we investigated whether spike proteins of SARS-CoV-2 induce LDs in human peripheral blood mononuclear cells (PBMCs) and in pulmonary microvascular endothelial cells (HPMECs). PBMCs or HPMECs were incubated alone or with endotoxin-free recombinant variants of trimeric spike glycoproteins (Alpha, Beta, Delta, and Omicron, 12 µg/mL). Afterward, cells were stained with Oil Red O for LDs, cytokine release was determined through ELISA, and the gene expression was analyzed through real-time PCR using TaqMan assays. Our data show that spikes induce LDs in PBMCs but not in HPMECs. In line with this, in PBMCs, spike proteins lower the expression of genes involving lipid metabolism and LD formation, such as SREBF1, HMGCS1, LDLR, and CD36. On the other hand, PBMCs exposed to spikes for 6 or 18 h did not increase in IL-1β, IL-6, IL-8, MCP-1, and TNFα release or expression as compared to non-treated controls. Thus, spike-induced LD formation in PBMCs seems to not be related to cell inflammatory activation. Further detailed studies are warranted to investigate in which specific immune cells spikes induce LDs, and what are the pathophysiological mechanisms and consequences of this induction in vivo.
- 9 September 2023
- Published by European Respiratory Society (ERS) in European Respiratory Journal
- Vol. 62 (suppl 67) , PA4679
Effects of patient serum containing different profiles and magnitudes of inflammatory markers on human microvascular lung endothelial and bronchial epithelial cells
The hyperactivation of the immune system could result in acute respiratory distress syndrome. We used serum from clinically well-characterized COVID-19 patients with severe (n=10) and moderate (n=9) disease to analyze which profiles and levels of pro- and anti-inflammatory markers affect human microvascular lung endothelial (EC) and bronchial epithelial (EpC) cells, in vitro. According to the cytokine/chemokine/inflammatory marker multiplex assay, most of the markers were elevated in severe patients whereas statistically higher levels were found only for soluble ICAM-1 and IL-17. Next, serum from each patient was added to EC (5%) and EpC (2%) for 18 h. We observed a marked induction of IL-8/CXCL8 release and expression in EpC and EC exposed to the serum of severe but not moderate COVID-19 patients. We also analyzed cell responses to patient serum based on the levels of inflammatory markers, independently of the disease severity. Serum containing higher levels of chemokines (IL-8 and MCP-1), and soluble ICAM-1 significantly activated both lung EC and EpC. Specifically, serum containing higher levels of soluble ICAM-1 increased FITM2 mRNA in EpC and VEGFA mRNA in EC. The EC treated with serum containing less MCP-1 and IL-8 showed a higher expression of PECAM1. We demonstrate divergent responses of EC and EpC to patient serum containing different levels and profiles of inflammation markers and that in vitro models of human lung cells can be useful to study respiratory system injuries.
- 9 September 2023
- Published by European Respiratory Society (ERS) in European Respiratory Journal
- Vol. 62 (suppl 67) , PA4679
Effects of patient serum containing different profiles and magnitudes of inflammatory markers on human microvascular lung endothelial and bronchial epithelial cells
The hyperactivation of the immune system could result in acute respiratory distress syndrome. We used serum from clinically well-characterized COVID-19 patients with severe (n=10) and moderate (n=9) disease to analyze which profiles and levels of pro- and anti-inflammatory markers affect human microvascular lung endothelial (EC) and bronchial epithelial (EpC) cells, in vitro. According to the cytokine/chemokine/inflammatory marker multiplex assay, most of the markers were elevated in severe patients whereas statistically higher levels were found only for soluble ICAM-1 and IL-17. Next, serum from each patient was added to EC (5%) and EpC (2%) for 18 h. We observed a marked induction of IL-8/CXCL8 release and expression in EpC and EC exposed to the serum of severe but not moderate COVID-19 patients. We also analyzed cell responses to patient serum based on the levels of inflammatory markers, independently of the disease severity. Serum containing higher levels of chemokines (IL-8 and MCP-1), and soluble ICAM-1 significantly activated both lung EC and EpC. Specifically, serum containing higher levels of soluble ICAM-1 increased FITM2 mRNA in EpC and VEGFA mRNA in EC. The EC treated with serum containing less MCP-1 and IL-8 showed a higher expression of PECAM1. We demonstrate divergent responses of EC and EpC to patient serum containing different levels and profiles of inflammation markers and that in vitro models of human lung cells can be useful to study respiratory system injuries.
- Open Access
- 25 July 2023
- Published by MDPI AG in Preprints.org
Human PBMCs Form Lipid Droplets in Response to Spike Proteins
Intracellular lipid droplets (LDs) can occur in response to inflammation, metabolic stresses, and other physiological/pathological processes. Herein, we investigated whether spike proteins of SARS-CoV-2 induce LDs in human peripheral blood mononuclear cells (PBMCs) and in pulmonary microvascular endothelial cells (HPMEC). PBMCs or HPMEC were incubated alone or with endotoxin-free recombinant variants of trimeric spike glycoproteins (Alpha, Beta, Delta, and Omicron, 12 µg/ml). Afterwards, cells were stained with Oil Red O for LDs, cytokine release was determined by ELISA, and the gene expression was analyzed by real-time PCR using TaqMan assays. Our data show that spikes induce LDs in PBMCs but not in HPMEC. In line, in PBMCs spike proteins lower expression of genes involving lipid metabolism and LDs formation, such as SREBF1, HMGCS1, LDLR, and CD36. On the other hand, PBMCs exposed to spikes for 6 or 18 h did not increase in IL-1β, IL-6, IL-8, MCP-1, and TNFα release or expression as compared to non-treated controls. Thus, spike-induced LDs formation in PBMCs seems to be not related to cell inflammatory activation. Further detailed studies are warranted to investigate in which specific immune cells spikes induce LDs, and what are pathophysiological mechanisms and consequences of this induction in vivo.
- 25 July 2023
- Published by MDPI AG in Preprints.org
Open AccessHuman PBMCs Form Lipid Droplets in Response to Spike Proteins
Intracellular lipid droplets (LDs) can occur in response to inflammation, metabolic stresses, and other physiological/pathological processes. Herein, we investigated whether spike proteins of SARS-CoV-2 induce LDs in human peripheral blood mononuclear cells (PBMCs) and in pulmonary microvascular endothelial cells (HPMEC). PBMCs or HPMEC were incubated alone or with endotoxin-free recombinant variants of trimeric spike glycoproteins (Alpha, Beta, Delta, and Omicron, 12 µg/ml). Afterwards, cells were stained with Oil Red O for LDs, cytokine release was determined by ELISA, and the gene expression was analyzed by real-time PCR using TaqMan assays. Our data show that spikes induce LDs in PBMCs but not in HPMEC. In line, in PBMCs spike proteins lower expression of genes involving lipid metabolism and LDs formation, such as SREBF1, HMGCS1, LDLR, and CD36. On the other hand, PBMCs exposed to spikes for 6 or 18 h did not increase in IL-1β, IL-6, IL-8, MCP-1, and TNFα release or expression as compared to non-treated controls. Thus, spike-induced LDs formation in PBMCs seems to be not related to cell inflammatory activation. Further detailed studies are warranted to investigate in which specific immune cells spikes induce LDs, and what are pathophysiological mechanisms and consequences of this induction in vivo.
- Open Access
- 26 July 2021
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 22 (15) , 7941
Boosted Pro-Inflammatory Activity in Human PBMCs by Lipopolysaccharide and SARS-CoV-2 Spike Protein Is Regulated by α-1 Antitrypsin
For the treatment of severe COVID-19, supplementation with human plasma-purified α-1 antitrypsin (AAT) to patients is currently considered. AAT inhibits host proteases that facilitate viral entry and possesses broad anti-inflammatory and immunomodulatory activities. Researchers have demonstrated that an interaction between SARS-CoV-2 spike protein (S) and lipopolysaccharides (LPS) enhances pro-inflammatory responses in vitro and in vivo. Hence, we wanted to understand the potential anti-inflammatory activities of plasma-derived and recombinant AAT (recAAT) in a model of human total peripheral blood mononuclear cells (PBMCs) exposed to a combination of CHO expressed trimeric spike protein and LPS, ex vivo. We confirmed that cytokine production was enhanced in PBMCs within six hours when low levels of LPS were combined with purified spike proteins (“spike”). In the presence of 0.5 mg/mL recAAT, however, LPS/spike-induced TNF-α and IL-1β mRNA expression and protein release were significantly inhibited (by about 46–50%) relative to LPS/spike alone. Although without statistical significance, recAAT also reduced production of IL-6 and IL-8. Notably, under the same experimental conditions, the plasma-derived AAT preparation Respreeza (used in native and oxidized forms) did not show significant effects. Our findings imply that an early pro-inflammatory activation of human PBMCs is better controlled by the recombinant version of AAT than the human plasma-derived AAT used here. Considering the increasing clinical interest in AAT therapy as useful to ameliorate the hyper-inflammation seen during COVID-19 infection, different AAT preparations require careful evaluation.
- 26 July 2021
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 22 (15) , 7941
Open AccessBoosted Pro-Inflammatory Activity in Human PBMCs by Lipopolysaccharide and SARS-CoV-2 Spike Protein Is Regulated by α-1 Antitrypsin
For the treatment of severe COVID-19, supplementation with human plasma-purified α-1 antitrypsin (AAT) to patients is currently considered. AAT inhibits host proteases that facilitate viral entry and possesses broad anti-inflammatory and immunomodulatory activities. Researchers have demonstrated that an interaction between SARS-CoV-2 spike protein (S) and lipopolysaccharides (LPS) enhances pro-inflammatory responses in vitro and in vivo. Hence, we wanted to understand the potential anti-inflammatory activities of plasma-derived and recombinant AAT (recAAT) in a model of human total peripheral blood mononuclear cells (PBMCs) exposed to a combination of CHO expressed trimeric spike protein and LPS, ex vivo. We confirmed that cytokine production was enhanced in PBMCs within six hours when low levels of LPS were combined with purified spike proteins (“spike”). In the presence of 0.5 mg/mL recAAT, however, LPS/spike-induced TNF-α and IL-1β mRNA expression and protein release were significantly inhibited (by about 46–50%) relative to LPS/spike alone. Although without statistical significance, recAAT also reduced production of IL-6 and IL-8. Notably, under the same experimental conditions, the plasma-derived AAT preparation Respreeza (used in native and oxidized forms) did not show significant effects. Our findings imply that an early pro-inflammatory activation of human PBMCs is better controlled by the recombinant version of AAT than the human plasma-derived AAT used here. Considering the increasing clinical interest in AAT therapy as useful to ameliorate the hyper-inflammation seen during COVID-19 infection, different AAT preparations require careful evaluation.